A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer
Clinical trial NCT03972150 · COMPLETED
Trial details
- NCT number
- NCT03972150
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2020-10-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.